Cargando…
Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
BACKGROUND: Identifying factors conferring responses to therapy in cancer is critical to select the best treatment for patients. For immune checkpoint inhibition (ICI) therapy, mounting evidence suggests that the gut microbiome can determine patient treatment outcomes. However, the extent to which g...
Autores principales: | Limeta, Angelo, Ji, Boyang, Levin, Max, Gatto, Francesco, Nielsen, Jens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7714408/ https://www.ncbi.nlm.nih.gov/pubmed/33268597 http://dx.doi.org/10.1172/jci.insight.140940 |
Ejemplares similares
-
Leveraging high-resolution omics data for predicting responses and adverse events to immune checkpoint inhibitors
por: Limeta, Angelo, et al.
Publicado: (2023) -
Analysis of normal levels of free glycosaminoglycans in urine and plasma in adults
por: Bratulic, Sinisa, et al.
Publicado: (2022) -
Plasma and Urine Free Glycosaminoglycans as Monitoring and Predictive Biomarkers in Metastatic Renal Cell Carcinoma: A Prospective Cohort Study
por: Gatto, Francesco, et al.
Publicado: (2023) -
Combined Immunotherapy in Metastatic Melanoma with Unknown Primary
por: Khan, Yasir, et al.
Publicado: (2019) -
Human gut microbiota and healthy aging: Recent developments and future prospective
por: Kumar, Manish, et al.
Publicado: (2016)